Pfizer’s flagship Covid drug can have dangerous interactions with common medications, a review has found. Paxlovid gained emergency use authorization in the US in December last year as an antiviral drug to treat mild to moderate Covid in high-risk patients. It has been given to millions of vulnerable Americans with underlying health conditions — reducing their risk of death by up to 90 per cent.
Lees het volledige artikel: